Beckwith-Wiedemann Syndrome: Growth Pattern and Tumor Risk according to Molecular Mechanism, and Guidelines for Tumor Surveillance
Frédéric Brioude(Inserm), Sylvie Rossignol(Université de Limoges), Yves Le Bouc(Inserm), Irène Netchine(Inserm), Alix M.B. Lacoste(Sorbonne Université), Christine Gicquel(Inserm), Marion Gauthier‐Villars, M.-P. Vazquez(Délégation Paris 5), Laurence Brugières(Institut Gustave Roussy), G. Audry(Sorbonne Université), F. Auber(Sorbonne Université)
Cited by 157
Related Papers
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
|Nature|1998|2.4k
Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|641
Child Health, Developmental Plasticity, and Epigenetic Programming
|Endocrine Reviews|2010|625
Clinical and molecular diagnosis, screening and management of Beckwith–Wiedemann syndrome: an international consensus statement
|Nature Reviews Endocrinology|2018|596